IRISYS, INC.
THIS TASK ORDER (TO) IS TO PROVIDE DOSAGE FORM DEVELOPMENT, MANUFACTURE AND STABILITY STUDIES OF ORC-13661 FOR PHASE II CLINICAL TRIAL
THIS TASK ORDER (TO) IS TO PROVIDE DOSAGE FORM DEVELOPMENT, MANUFACTURE AND STABILITY STUDIES OF ORC-13661 FOR PHASE II CLINICAL TRIAL is a funding opportunity from IRISYS, INC., up to 180000, closing July 31, 2027.
Jul 31, 2027
(365d left)Overview
Dosage Form Development, Manufacture and Stability Studies of ORC-13661 for Phase II Clinical Trial